Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19
| Autor: | Juan Carlos Malpartida, Joshua Davis, Jacob Mok, Cuilan Gao, Harish Manyam, Kimberly O’Dell |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty pulmonary embolism Coronavirus disease 2019 (COVID-19) Substance-Related Disorders heart failure Comorbidity 030204 cardiovascular system & hematology 03 medical and health sciences Peripheral Arterial Disease 0302 clinical medicine Risk Factors Internal medicine medicine Humans Diseases of the circulatory (Cardiovascular) system 030212 general & internal medicine Vascular Diseases Stroke Heart Failure and Cardiomyopathies Aged Ischemic Stroke Retrospective Studies Aged 80 and over business.industry SARS-CoV-2 Case-control study COVID-19 Anticoagulants Retrospective cohort study Venous Thromboembolism Length of Stay Middle Aged medicine.disease Prognosis stroke Pulmonary embolism Hospitalization Heart failure Case-Control Studies RC666-701 Female Hydroxymethylglutaryl-CoA Reductase Inhibitors Cardiology and Cardiovascular Medicine business Venous thromboembolism |
| Zdroj: | Open Heart, Vol 8, Iss 1 (2021) Open Heart |
| ISSN: | 2053-3624 |
| Popis: | BackgroundPrior diagnosis of heart failure (HF) is associated with increased length of hospital stay (LOS) and mortality from COVID-19. Associations between substance use, venous thromboembolism (VTE) or peripheral arterial disease (PAD) and its effects on LOS or mortality in patients with HF hospitalised with COVID-19 remain unknown.ObjectiveThis study identified risk factors associated with poor in-hospital outcomes among patients with HF hospitalised with COVID-19.MethodsCase–control study was conducted of patients with prior diagnosis of HF hospitalised with COVID-19 at an academic tertiary care centre from 1 January 2020 to 28 February 2021. Patients with HF hospitalised with COVID-19 with risk factors were compared with those without risk factors for clinical characteristics, LOS and mortality. Multivariate regression was conducted to identify multiple predictors of increased LOS and in-hospital mortality in patients with HF hospitalised with COVID-19.ResultsTotal of 211 patients with HF were hospitalised with COVID-19. Women had longer LOS than men (9 days vs 7 days; pConclusionVascular diseases increase LOS and mortality in patients with HF hospitalised with COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|